Metabolic hepatic steatosis with ultrasound in type 2 diabetics at the national hospital and university center -Hubert Koutoukou Maga in Cotonou in Benin in 2019: prevalence and associated factors

Abstract

Introduction: Hepatic steatosis can progress to cirrhosis and hepatocellular carcinoma. The objective of this study was to determine the ultrasound prevalence and factors associated with metabolic hepatic steatosis in type 2 diabetics at the CNHU-HKM of Cotonou. Patients and Method: Descriptive and analytical cross-sectional study carried out over 4 months in the medical imaging department of the CNHU-HKM of Cotonou on type 2 diabetic patients. Hepatic steatosis was diagnosed by ultrasound (hyperechogenicity of the liver in relation to the renal cortex) and classified into mild, moderate and severe stages using a visual scale. Only moderate and severe forms were retained in order to limit bias.Results: 139 patients were included (mean age 57.46 years, sex ratio 0.6;). The prevalence of hepatic steatosis was 38%. It was moderate in 79.25% and severe in 20.75% of patients. Body mass index, abdominal obesity, hepatomegaly, metabolic syndrome, and long-standing diabetes were significantly associated with hepatic steatosis. Conclusion: The prevalence of metabolic hepatic steatosis is high among type 2 diabetics at the CNHU-HKM. Several factors, some of which are modifiable, are associated with it.